The FDA has approved lerodalcibep-liga, a third-generation injectable PCSK9 inhibitor, to reduce LDL cholesterol in adults ...
In this video, Erika Hamilton, MD, discusses HER2CLIMB-05 trial results demonstrating that the addition of tucatinib to maintenance therapy delayed metastatic breast cancer progression for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback